ABCL Abcellera Biologics Inc.

$11.56 +1.76%

Updated 17 d ago

Healthcare · Pharmaceutical Preparations

Abcellera Biologics Inc. (ABCL) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $3.5 billion. Shares last traded at $11.56, 8.0% below their 52-week high. Over the past year the stock is up 190.5%. Net profit margin is -248.8%, below the peer median of -8.9%. Revenue grew 160.6% year over year.

Market Cap

$3.5B

Shares Out

306.6M

EPS (TTM)

$-1.19

P/E Ratio

—

P/S Ratio

53.56

P/B Ratio

3.96

Dividend / Share

—

Dividend Yield

—

52-Week High

$12.56

52-Week Low

$2.75

Volume

251,047

Avg Vol (3m)

410,161.063

Performance

-7.63%

+101.04%

+81.76%

+220.67%

YTD

+239.00%

+190.45%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

62.24

SMA (50)

$8.33

SMA (200)

$5.10

Price vs SMA50

+38.84%

Price vs SMA200

+126.70%

ATR (14)

$0.81

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$66M

Net Income

$-165M

Gross Margin

—

Operating Margin

-340.3%

Net Margin

-248.8%

Return on Equity

-18.4%

Return on Assets

-12.6%

Current Ratio

12.77

Debt / Equity

0.46

Revenue Growth (YoY)

+160.6%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.32	2026-08-05
Q1 2026	$-0.14	2026-05-11
FY 2025	$-0.49	2026-02-24
Q3 2025	$-0.46	2025-11-06
Q2 2026	$-0.27	2026-08-05
Q1 2026	$-0.15	2026-05-11

Full earnings history →

Pharmaceutical Preparations peers

ABCL vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 17 d ago

P/S vs peers

53.56 / 11.11 med

+382% premium

Net margin vs peers

-248.8% / -8.9% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.